Comparative Efficacy of PD‐1 Inhibitor‐Based Neoadjuvant Chemoimmunotherapy Regimens for Resectable Stage II–IIIa NSCLC: A Real‐World Retrospective Study

ABSTRACT Background Although neoadjuvant chemoimmunotherapy has emerged as a promising approach for resectable non‐small cell lung cancer (NSCLC), comparative real‐world data on different PD‐1 inhibitors are limited. This study compared the clinical efficacy, pathological response, survival, and saf...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Bo Yan, Xiaoxuan Sun, Yan Sheng, Ran Zhang, Yanjun Su, Yulong Chen
Format: Artigo
Jezik:Inglês
Izdano: Wiley 2025-07-01
Serija:Thoracic Cancer
Teme:
chemoimmunotherapy
immune checkpoint inhibitors
neoadjuvant therapy
non‐small cell lung cancer
surgery
Online dostop:https://doi.org/10.1111/1759-7714.70123
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki